Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Upregulation of PD-L1 on Myeloma Cells By Immunomodulatory Agents Potentiates the Effect of Durvalumab

Blood (2018) 132 (Supplement 1): 4439.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals